Search

everythinglearnresearchcommunity

for

Search:↓

Splitting non-scored tablets can lead to uneven drug distribution, posing risks.

Cholesterol and phospholipids increase in mouse skin during cancer development, with differences between male and female skin.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Glutamine may protect against alopecia areata, while certain cholesterol and glucose levels may increase risk.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Lower SHBG levels may increase the risk of PCOS.

A patient with a thick scalp and hair loss was correctly diagnosed with alopecia areata and a thick scalp fat layer, not lipedematous alopecia, and regrew hair after treatment.

A new topical treatment using micelles shows promise for safer and more effective hair regrowth in androgenetic alopecia.

The document describes a way to measure biotin in blood to prevent wrong test results in hormone level testing.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Lipase H is important for hair follicle function and shaping hair fibers.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

Moderately lipophilic dyes penetrate skin deeply, while highly hydrophobic or lipophilic dyes stay on the surface.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

PLGA nanospheres in cosmetics improve skin and hair treatment effectiveness.

Glycosaminoglycan levels peak early in hair growth and decrease as the cycle progresses.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Sebum samples remain stable under various storage conditions, making them suitable for remote and at-home testing.

Early detection of Graham-Little-Piccardi-Lasseur syndrome is key for better management.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

The uric acid to creatinine ratio is a strong indicator for diagnosing PCOS.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

Sebaceous gland atrophy and abnormal function may contribute to hair loss in psoriasis.

PCL nanoscaffold-based liver spheroids are effective for drug screening and studying liver toxicity.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.